New Sickle Cell Disease Clinical Trials in the UK
Despite years of research and development, treatment options for patients with sickle cell disease remain limited. More recently, companies and researchers have started to develop new therapies to help improve patient lives. Clinical studies help researchers better understand a disease and how best to treat it, with the ultimate goal to develop new treatments for patients. Join the Sickle Cell Society and Imara Inc for a Sunday lunch to learn about new clinical studies for adult patients living with sickle cell disease being conducted in the UK. Book your free place here.
Imara Inc., is a U.S.-based company focused on advancing novel treatments for sickle cell disease and other hemoglobinopathies.
Book your free place here: https://clinicaltrialevent.eventbrite.com
|Guests Arrive and Register||–||1200 – 1230|
|LUNCH||–||1230 – 1330|
|Welcome||John James – CEO Sickle Cell Society||13:35 – 1345|
|Importance of Research & Development, current clinical trials
and the unmet medical need in Sickle Cell Disease.
Dr Perla Eleftheriou – UCLH
|1345 – 1415|
|COFFEE BREAK||/||1415 – 1430|
|Scientific Data IMR 687||Dr James McArthur – Imara||1430 – 1510|
|Phase 1 Data IMR 687||Dr Shi Yin Foo – Cydan II||1510 – 1535|
|Phase 2a study||Dr Arne Dekreuk – Croydon University Hospital||1535 – 1550|
|Questions and Answer Session||–||1550 -1610|